Boronated biopolymer crosslinking agents and methods relating thereto

US9688906B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9688906-B2
Application numberUS-201414362605-A
CountryUS
Kind codeB2
Filing dateJan 23, 2014
Priority dateJul 1, 2013
Publication dateJun 27, 2017
Grant dateJun 27, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Boronated biopolymer crosslinking agents useful in producing viscosified treatment fluids that include an aqueous fluid, a base polymer, and the boronated biopolymer crosslinking agent, wherein the boronated biopolymer crosslinking agent comprises a biopolymer derivatized with a boronic acid, a boronate ester, or both. Such viscosified treatment fluids may be useful in fracturing operations, gravel packing operations, drilling operations, and the like.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method comprising: introducing a viscosified treatment fluid into a wellbore penetrating a subterranean formation, the viscosified treatment fluid comprising an aqueous fluid, a base polymer, and a boronated biopolymer crosslinking agent, wherein the boronated biopolymer crosslinking agent consists of a biopolymer derivatized with a boronic acid, a boronate ester, or both formed by reacting the biopolymer and the boronic acid, the boronate ester, or both in the presence of a coupling agent selected from the group consisting of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and N,N′-dicyclohexylcarbodiimide (DCC), wherein the biopolymer is selected from the group consisting of guar gum, oxidized guar, hydroxyethyl guar, hydroxypropyl guar, carboxymethyl guar, carboxymethylhydroxvethyl guar, carboxymethylhydroxypropyl guar, a cellulose, a cellulose derivative selected from hydroxyethyl cellulose, carboxyethylcellulose, carboxymethylcellulose, carboxymethylhydroxvethylcellulose, methyl cellulose, ethylcellulose, methylhydroxyethyl cellulose, xanthan, scleroglucan, succinoglycan, diutan, an alginate, a pectinate, chitosan, a hyaluronic acid, a polysaccharide, a polypeptide, and any combination thereof, wherein the boronic acid or boronate ester is selected from the group consisting of bromopentyl boronic acid, chloromethylvinyl boronic acid, 4-cyanophenylboronic acid, esters with pinacol, formylphenyl boronic acids, carboxyphenyl boronic acids, bromomethyl boronic acid, alkoxycarbonyl boronic acids, formylphenyl boronic acid pinacol ester, and any combination thereof, and wherein the boronated biopolymer crosslinking agent in the viscosified treatment fluid requires about 25% to about 50% lower base polymer concentration to produce the same viscosity as a viscosified treatment fluid comprising the same base polymer and sodium pentaborate crosslinking agent. 2. The method of claim 1 , wherein the base polymer a natural polymer selected from the group consisting of guar, a guar derivative, hydroxypropylguar, oxidized guar, carboxymethylhydroxypropylguar, carboxymethyl guar, hydrophobically modified guar derivative, locust bean gum, a locust bean gum derivative, fenugreek gum, a fenugreek gum derivative, tara gum, a tara gum derivative, and any combination thereof. 3. The method of claim 1 , wherein the base polymer comprises a synthetic polymer selected from the group consisting of a polyol, a polyvinyl alcohol, a polymer comprising a monomer having a 1,4 diol substitution, a polymer comprising a monomer having a 1,3 diol substitution, a polymer comprising a monomer having a 1,2 diol substitution, and any combination thereof. 4. The method of claim 1 , wherein the base polymer has a molecular weight of about 100,000 g/mol to about 5,000,000 g/mol. 5. The method of claim 1 , wherein the base polymer is at about 0.1% to about 10% by weight of the viscosified treatment fluid. 6. The method of claim 1 , wherein the boronated biopolymer crosslinking agent has a molecular weight of about 1,000 g/mol to about 5,000,000 g/mol. 7. The method of claim 1 , wherein the boronated biopolymer crosslinking agent has a boron weight percent of about 0.005% to about 0.05% by weight of the boronated biopolymer crosslinking agent. 8. The method of claim 1 , wherein the boronated biopolymer crosslinking agent and the base polymer are each at about 10 lb/gal in the viscosified treatment fluid. 9. The method of claim 1 , wherein the treatment fluid is an invert emulsion. 10. The method of claim 1 , wherein introducing is at a pressure sufficient to create or extend at least one fracture in the subterranean formation. 11. The method of claim 1 further comprising: drilling at least a portion of the wellbore with the viscosified treatment fluid. 12. The method of claim 1 , wherein the viscosified treatment fluid further comprises a plurality of particulates; and the method further comprises forming a gravel pack comprising the particulates in an annulus within the wellbore. 13. The method of claim 1 further comprising: breaking the viscosified treatment fluid so as to reduce the viscosity of the viscosified treatment fluid. 14. A method comprising: introducing a first treatment fluid into a wellbore penetrating a subterranean formation at a pressure sufficient to create or extend at least one fracture in the subterranean formation; and forming a particulate pack in the fracture with a second treatment fluid, the second treatment fluid comprising an aqueous fluid, a base polymer, a boronated biopolymer crosslinking agent, and a plurality of particulates, wherein the boronated biopolymer crosslinking agent consists of a biopolymer derivatized with a boronic acid, a boronate ester, or both by reacting the biopolymer and the boronic acid, the boronate ester or both in the presence of a coupling agent selected from the group consisting of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) and N,N′-dicyclohexylcarbodiimide (DCC), wherein the biopolymer is selected from the group consisting of guar gum, oxidized guar, hydroxyethyl guar, hydroxypropyl guar, carboxymethyl guar, carboxymethylhydroxvethyl guar, carboxymethylhydroxypropyl guar, a cellulose, a cellulose derivative selected from hydroxyethyl cellulose, carboxyethylcellulose, carboxymethylcellulose, carboxymethylhydroxvethylcellulose, methyl cellulose, ethylcellulose, methylhydroxyethyl cellulose, xanthan, scleroglucan, succinoglycan, diutan, an alginate, a pectinate, chitosan, a hyaluronic acid, a polysaccharide, a polypeptide, and any combination thereof, wherein the boronic acid or boronate ester is selected from the group consisting of bromopentyl boronic acid, chloromethylvinyl boronic acid, 4-cyanophenylboronic acid, esters with pinacol, formylphenyl boronic acids, carboxyphenyl boronic acids, bromomethyl boronic acid, alkoxycarbonyl boronic acids, formylphenyl boronic acid pinacol ester, and any combination thereof, and wherein the boronated biopolymer crosslinking agent in the viscosified treatment fluid requires about 25% to about 50% lower base polymer concentration to produce the same viscosity as a viscosified treatment fluid comprising the same base polymer and sodium pentaborate crosslinking agent. 15. The method of claim 14 further comprising: breaking the second treatment fluid so as to reduce the viscosity of the second treatment fluid.

Assignees

Inventors

Classifications

  • Compositions containing polymers · CPC title

  • Gravelling of wells · CPC title

  • containing cross-linking agents · CPC title

  • of natural origin, e.g. polysaccharides, cellulose · CPC title

  • C09K8/685Primary

    containing cross-linking agents · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9688906B2 cover?
Boronated biopolymer crosslinking agents useful in producing viscosified treatment fluids that include an aqueous fluid, a base polymer, and the boronated biopolymer crosslinking agent, wherein the boronated biopolymer crosslinking agent comprises a biopolymer derivatized with a boronic acid, a boronate ester, or both. Such viscosified treatment fluids may be useful in fracturing operations, gr…
Who is the assignee on this patent?
Halliburton Energy Services Inc, Halliburton Energy Servics Inc
What technology area does this patent fall under?
Primary CPC classification C09K8/685. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).